Toward peptide receptor ligand drugs: progress on nonpeptides.
Freidinger
R M
RM
Medicinal Chemistry Department, Merck Research Laboratories, West Point, Pennsylvania 19486.
D000595:Amino Acid Sequence; D000818:Animals; D004723:Endorphins / Q000494:pharmacology; D006801:Humans; D008969:Molecular Sequence Data; D010455:Peptides / Q000494:pharmacology*; D011945:Receptors, Angiotensin / Q000187:drug effects; D011956:Receptors, Cell Surface / Q000187:drug effects*; D011949:Receptors, Cholecystokinin / Q000187:drug effects; D018041:Receptors, Neurokinin-2; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D011957:Receptors, Opioid / Q000187:drug effects; D017483:Receptors, Vasopressin / Q000187:drug effects
D004723:Endorphins; D010455:Peptides; D011945:Receptors, Angiotensin; D011956:Receptors, Cell Surface; D011949:Receptors, Cholecystokinin; D018041:Receptors, Neurokinin-2; D017981:Receptors, Neurotransmitter; D011957:Receptors, Opioid; D017483:Receptors, Vasopressin